Literature DB >> 11529927

Th2 dominance in nasal mucosa in patients with Wegener's granulomatosis.

C E Balding1, A J Howie, A B Drake-Lee, C O Savage.   

Abstract

Wegener's granulomatosis initially affects upper respiratory tract organs including the nasal mucosa in more than 90% of patients. The inflammation is typically granulomatous with associated vasculitis. T lymphocytes are usually a prominent component of the leucocyte infiltrate. Previous studies using peripheral blood T cells have implicated IFN-gamma rich Th1-type responses. This study addressed the cytokine milieu in nasal mucosa from 10 patients with active Wegener's granulomatosis using immunohistochemistry. Increased levels of CD3+ T cells and eosinophils were present compared with normal and disease controls. There was increased expression of IL-4, down-regulation of IL-2 and no detectable IFN-gamma. There was increased expression of the chemokine receptor CCR3 by infiltrating cells, consistent with an IL-4 dominant, Th2-biased response. In contrast, renal biopsy tissue from 10 patients with active Wegener's granulomatosis showed expression of IL-2 and IL-4. The Th2-type environment within nasal mucosa, often the initial site of disease activity in Wegener's, is consistent with a local allergic response in these patients.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11529927      PMCID: PMC1906130          DOI: 10.1046/j.1365-2249.2001.125002332.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  19 in total

1.  Wegener's granulomatosis: pathology and review of the literature.

Authors:  G C GODMAN; J CHURG
Journal:  AMA Arch Pathol       Date:  1954-12

2.  Anti-myeloperoxidase antibodies stimulate neutrophils to damage human endothelial cells.

Authors:  B H Ewert; J C Jennette; R J Falk
Journal:  Kidney Int       Date:  1992-02       Impact factor: 10.612

Review 3.  Glycosaminoglycans contribute to multiple functions of vascular endothelial cells.

Authors:  P Cockwell; D H Adams; C O Savage
Journal:  Clin Exp Immunol       Date:  1996-04       Impact factor: 4.330

Review 4.  Nomenclature of systemic vasculitides. Proposal of an international consensus conference.

Authors:  J C Jennette; R J Falk; K Andrassy; P A Bacon; J Churg; W L Gross; E C Hagen; G S Hoffman; G G Hunder; C G Kallenberg
Journal:  Arthritis Rheum       Date:  1994-02

5.  An interdisciplinary approach to the care of patients with Wegener's granulomatosis: long-term outcome in 155 patients.

Authors:  E Reinhold-Keller; N Beuge; U Latza; K de Groot; H Rudert; B Nölle; M Heller; W L Gross
Journal:  Arthritis Rheum       Date:  2000-05

6.  Defining protective responses to pathogens: cytokine profiles in leprosy lesions.

Authors:  M Yamamura; K Uyemura; R J Deans; K Weinberg; T H Rea; B R Bloom; R L Modlin
Journal:  Science       Date:  1991-10-11       Impact factor: 47.728

7.  T cell reactivity to proteinase 3 and myeloperoxidase in patients with Wegener's granulomatosis (WG).

Authors:  E Brouwer; C A Stegeman; M G Huitema; P C Limburg; C G Kallenberg
Journal:  Clin Exp Immunol       Date:  1994-12       Impact factor: 4.330

8.  Autoantibodies developing to myeloperoxidase and proteinase 3 in systemic vasculitis stimulate neutrophil cytotoxicity toward cultured endothelial cells.

Authors:  C O Savage; B E Pottinger; G Gaskin; C D Pusey; J D Pearson
Journal:  Am J Pathol       Date:  1992-08       Impact factor: 4.307

9.  T cell responses to myeloperoxidase (MPO) and proteinase 3 (PR3) in patients with systemic vasculitis.

Authors:  M E Griffith; A Coulthart; C D Pusey
Journal:  Clin Exp Immunol       Date:  1996-02       Impact factor: 4.330

10.  Wegener's granulomatosis autoantibodies identify a novel diisopropylfluorophosphate-binding protein in the lysosomes of normal human neutrophils.

Authors:  R Goldschmeding; C E van der Schoot; D ten Bokkel Huinink; C E Hack; M E van den Ende; C G Kallenberg; A E von dem Borne
Journal:  J Clin Invest       Date:  1989-11       Impact factor: 14.808

View more
  15 in total

Review 1.  Off balance: T-cells in antineutrophil cytoplasmic antibody (ANCA)-associated vasculitides.

Authors:  P Lamprecht
Journal:  Clin Exp Immunol       Date:  2005-08       Impact factor: 4.330

Review 2.  Autoantigen complementarity: a new theory implicating complementary proteins as initiators of autoimmune disease.

Authors:  William F Pendergraft; Barrak M Pressler; J Charles Jennette; Ronald J Falk; Gloria A Preston
Journal:  J Mol Med (Berl)       Date:  2004-12-11       Impact factor: 4.599

Review 3.  Glomerulonephritis, Th1 and Th2: what's new?

Authors:  P G Tipping; A R Kitching
Journal:  Clin Exp Immunol       Date:  2005-11       Impact factor: 4.330

Review 4.  T cells in ANCA-associated vasculitis: what can we learn from lesional versus circulating T cells?

Authors:  Benjamin Wilde; Marielle Thewissen; Jan Damoiseaux; Pieter van Paassen; Oliver Witzke; Jan Willem Cohen Tervaert
Journal:  Arthritis Res Ther       Date:  2010-02-24       Impact factor: 5.156

Review 5.  Eosinophils in vasculitis: characteristics and roles in pathogenesis.

Authors:  Paneez Khoury; Peter C Grayson; Amy D Klion
Journal:  Nat Rev Rheumatol       Date:  2014-07-08       Impact factor: 20.543

6.  Production of antineutrophil cytoplasm antibodies derived from circulating B cells in patients with systemic vasculitis.

Authors:  A R Clayton; C O S Savage
Journal:  Clin Exp Immunol       Date:  2003-04       Impact factor: 4.330

Review 7.  Update on pathogenic mechanisms of systemic necrotizing vasculitis.

Authors:  Maria I Danila; S Louis Bridges
Journal:  Curr Rheumatol Rep       Date:  2008-12       Impact factor: 4.592

8.  Increased frequency of CCR4+ and CCR6+ memory T-cells including CCR7+CD45RAmed very early memory cells in granulomatosis with polyangiitis (Wegener's).

Authors:  Ursula Fagin; Silke Pitann; Wolfgang L Gross; Peter Lamprecht
Journal:  Arthritis Res Ther       Date:  2012-04-10       Impact factor: 5.156

9.  Aberrant cytokine pattern of the nasal mucosa in granulomatosis with polyangiitis.

Authors:  Janet Wohlers; Katrin Breucker; Rainer Podschun; Jürgen Hedderich; Peter Lamprecht; Petra Ambrosch; Martin Laudien
Journal:  Arthritis Res Ther       Date:  2012-10-17       Impact factor: 5.156

Review 10.  [Vasculitides and eosinophilic pulmonary diseases].

Authors:  C Kroegel; M Foerster; S Quickert; H Slevogt; T Neumann
Journal:  Internist (Berl)       Date:  2018-09       Impact factor: 0.834

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.